Relapsing Multiple Sclerosis (RMS) Completed Phase 3 Trials for Ponesimod (DB12016)

Also known as: Multiple Sclerosis Relapse / Relapsed Multiple sclerosis / Relapsing Multiple Sclerosis / Multiple sclerosis flare

IndicationStatusPhase
DBCOND0044896 (Relapsing Multiple Sclerosis (RMS))Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02425644Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple SclerosisTreatment